Harvard Biotech Club Career Fair 2018


Tuesday, August 28, 2018, 12:00pm to 5:30pm


New Research Building, HMS 77 Avenue Louis Pasteur, Boston, MA, 02115

Keynote by: Dr. James Bradner, M.D., President of the Novartis Institutes for Biomedical Research (NIBR)



12:00 - 2:15pm     Panel Discussions: Pechet Room, NRB

Moderator:  Pearl Freier, President, Cambridge BioPartners, Inc.   

12:00 - 1:00pm

Opportunities to Work on Breakthrough Research

Pulmonary Hypertension Discovery Research · RNA-Targeted Small Molecules · Immune, Inflammatory, and Fibrotic Disorders · Gene Therapy for Neurological Disease

World class leaders from four of biopharma’s most exciting and innovative companies will share insights into their organizations, job and growth opportunities in their fields, approaches to building successful teams and hiring, the benefits and risks of working for small biotech companies and large biopharma organizations, and suggestions for transitioning from academia to industry.


David E. Gutstein, M.D.  Vice President, CVM Discovery Biology  @  Janssen Pharmaceuticals (a subsidiary of Johnson and Johnson)

Jennifer C. Petter, Ph.D.  Founder and Chief Scientific Officer  @  Arrakis Therapeutics

Robert Plenge, M.D., Ph.D.  Vice President, Translational Development, Research & Early Development and Head of the Inflammation & Immunology Thematic Center of Excellence Unit @ Celgene                 Blog: https://www.plengegen.com

Todd Carter, Ph.D.  Senior Director of Neuroscience  @  Voyager Therapeutics


1:15 - 2:15 pm

Nontraditional Career Paths for PhDs and MDs Outside of the Bench 

Business Development · Data Science · Venture Capital · Product development · Marketing · Intellectual Property · Management · Clinical Policy · Health Services · Commercialization strategy · Management

A wide variety of opportunities exist today for PhDs and MDs to impact human health outside of a career in drug discovery or clinical practice. Join our chat with leaders at world class Boston-area companies who will share their perspectives on their career trajectories. Discussion will also include growth opportunities and advice for transitioning into new areas


Aman Bhandari, Ph.D., MPH. VP Data Strategy and Solutions @ Vertex Pharmaceuticals

 Ivana Liebisch, Ph.D., JD.  EVP and Chief Business Oficer @  Ipsen  

Chandra Ramanathan, Ph.D., MBA.    Vice President and Head,  East Coast Innovation Center @ Bayer                           

Michael S Sherman, M.D., MBA. Senior Vice President & Chief Medical Officer @  Harvard Pilgrim Health Care 

Claire Leurent, Ph.D., MBA. Bio Sector Investment Director @ Samsung Ventures

Daniel Macaya Ph.D. Associate Director TechAtlas Division @ RA Capital


Sponsored and recorded by: Science Careers from the journal AAAS



1:00 - 5:00pm   Career Fair Recruiting Tables: Rotunda, NRB

Come and meet key recruitment personnel from industry leaders in the fields of pharma, biotech, consulting, medical communications, patent law, and more.Click here for a list of participating companies.

2:30 - 5:00pm    Company Presentations: Pechet Room, NRB

2:30 - 2:50pm   Clark+Elbing LLP

2:55 - 3:15pm    Vertex Pharmaceuticals Inc.

3:20 - 3:40pm   Safety Partners, Inc.

3:45 - 4:05pm   AbbVie

4:10 - 4:30pm    Foundation Medicine

4:35 - 4:55pm   AstraZeneca 

5:15pm - 6:00pm   Keynote Speaker: Jay Bradner, M.D.


James (Jay) Bradner, M.D.
President of the Novartis Institutes for BioMedical Research (NIBR)


James (Jay) Bradner, M.D., has been President of the Novartis Institutes for BioMedical Research (NIBR) since March 2016. He is a member of the Executive Committee of Novartis.

From 2005 through 2015, Dr. Bradner served on the research faculty of Harvard Medical School and as an attending physician in stem cell transplantation within the Department of Medical Oncology at the Dana-Farber Cancer Institute in the United States. He has co-founded five biotechnology companies and has co-authored more than 200 scientific publications and 30 US patent applications.

Dr. Bradner is a graduate of Harvard College and the University of Chicago Medical School in the US. He completed his residency in medicine at Brigham and Women's Hospital, his fellowship in medical oncology and hematology at the Dana-Farber Cancer Institute, and his postdoctoral training in chemistry and chemical biology at Harvard University. He has received many honorific awards and was elected into the American Society for Clinical Investigation in 2011 and the Alpha Omega Alpha Honor Medical Society in 2013.